9.44
-0.08 (-0.89%)
Previous Close | 9.52 |
Open | 9.55 |
Volume | 2,389,130 |
Avg. Volume (3M) | 5,299,219 |
Market Cap | 1,624,395,776 |
Price / Sales | 0.640 |
Price / Book | 1.13 |
52 Weeks Range | |
Earnings Date | 18 Feb 2025 - 24 Feb 2025 |
Profit Margin | -37.91% |
Operating Margin (TTM) | -6.30% |
Diluted EPS (TTM) | -5.78 |
Quarterly Revenue Growth (YOY) | -3.00% |
Total Debt/Equity (MRQ) | 105.38% |
Current Ratio (MRQ) | 1.73 |
Operating Cash Flow (TTM) | 337.86 M |
Levered Free Cash Flow (TTM) | 261.99 M |
Return on Assets (TTM) | -3.13% |
Return on Equity (TTM) | -51.65% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Mixed | Bearish |
Health Information Services (Global) | Mixed | Bearish | |
Stock | Teladoc Health, Inc. | Bullish | Bearish |
AIStockmoo Score
Analyst Consensus | 1.5 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -3.0 |
Average | -0.25 |
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Value |
% Held by Insiders | 0.82% |
% Held by Institutions | 77.00% |
52 Weeks Range | ||
Price Target Range | ||
High | 14.00 (Goldman Sachs, 48.38%) | Buy |
Median | 12.00 (27.19%) | |
Low | 8.00 (TD Cowen, -15.21%) | Hold |
Average | 11.80 (25.07%) | |
Total | 3 Buy, 2 Hold | |
Avg. Price @ Call | 9.49 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Piper Sandler | 04 Dec 2024 | 13.00 (37.78%) | Buy | 11.02 |
Goldman Sachs | 15 Nov 2024 | 14.00 (48.38%) | Buy | 9.21 |
Deutsche Bank | 01 Nov 2024 | 12.00 (27.19%) | Hold | 9.21 |
Barclays | 31 Oct 2024 | 12.00 (27.19%) | Buy | 9.00 |
TD Cowen | 31 Oct 2024 | 8.00 (-15.21%) | Hold | 9.00 |
No data within this time range.
Date | Type | Details |
---|---|---|
13 Jan 2025 | Announcement | Teladoc Health Joins Amazon’s Health Benefits Connector for Cardiometabolic Programs |
06 Jan 2025 | Announcement | Teladoc Health to Participate in Upcoming Investor Conference |
25 Nov 2024 | Announcement | Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution |
21 Nov 2024 | Announcement | Teladoc Health to Participate in Upcoming Investor Conference |
07 Nov 2024 | Announcement | Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 |
30 Oct 2024 | Announcement | Teladoc Health Reports Third Quarter 2024 Results |
16 Oct 2024 | Announcement | Teladoc Health to Announce Third Quarter 2024 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |